Evidence map›Paper›PMID 40320162›Full record

ArticleThe Journal of investigative dermatology2025

Eosinophils and Bioactive Lipid Mediators Regulate Skin Inflammation and Cancer Growth.

Christina Malactou, Mark Hayes, Tingfeng Zhang, Sophie Ward, Catherine Harwood, Jesmond Dalli, Jessica Strid

Abstract read
In one paragraph

Article in The Journal of investigative dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christina MalactouDepartment of Immunology and Inflammation, Imperial College London, London, United Kingdom.
Mark HayesDepartment of Immunology and Inflammation, Imperial College London, London, United Kingdom.
Tingfeng ZhangDepartment of Immunology and Inflammation, Imperial College London, London, United Kingdom.
Sophie WardDepartment of Immunology and Inflammation, Imperial College London, London, United Kingdom.
Catherine HarwoodCentre for Cell Biology and Cutaneous Research, Queen Mary University of London, London, United Kingdom.
Jesmond DalliWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom; Centre for Inflammation and Therapeutic Innovation, Queen Mary University of London, London, United Kingdom.
Jessica StridDepartment of Immunology and Inflammation, Imperial College London, London, United Kingdom. Electronic address: j.strid@imperial.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer, with local immunity playing a key role in regulating outcome. Nonresolving inflammation has been suggested to drive cancer growth; however, a fundamental understanding of the tumor immune microenvironment in cSCC is still lacking. In this study, we demonstrate tissue-associated tumor eosinophilia in both human and murine cSCC and show that eosinophils promote epithelial hyperplasia and tumor outgrowth. The skin eosinophils display tissue adaptation and dynamically alter their transcriptome according to the microenvironment. Furthermore, we show that the skin bioactive lipidome is significantly altered during inflammation and in cSCC and that this is regulated by eosinophils. Inflamed skin and cSCC tissue are dominated by lipid mediators synthesized by lipoxygenase enzymes, and our results suggest that eosinophils influence the balance between proinflammatory and proresolving lipid mediators. We demonstrate that lipid mediators can regulate epithelial cell expansion, with PCTR1 reducing inflammation-driven growth of tumor cells and eosinophil-driven eoxin C4 blocking this effect. Together, these findings highlight that eosinophils and specific bioactive lipid mediators play important roles in skin biology and carcinogenesis and point to potential previously unreported strategies for treatment of inflammatory disorders and epithelial malignancies.

Indexed as

Carcinoma, Squamous CellDermatitisEosinophilsSkin NeoplasmsAnimalsDisease Models, AnimalFemaleHumansLipid MetabolismMiceMice, Inbred C57BLSkinTumor MicroenvironmentBioactive lipid mediatorsCancerEosinophilsInflammationSkin

Identifiers

PMID40320162
PMCPMC7619174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.